Clinical trial · Observational
Ultrasound-guided Tru-cut Biopsy in Patients with Suspected Ovarian Cancer: Adequacy, Accuracy, Safety and Patient Assessment.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this prospective observational study is to evaluate the role of ultrasound-guided tru-cut biopsy (in the hands of an expert certified sonographer within a gynecological center)in patients with suspected ovarian cancer. The main questions it aims to answer are: Is the material from tru-cut biopsy adequate for histopathological and immunohistochemical examination? Is the material accurate in comparison with the final pathological specimen? What are the patient experience and complications after the procedure? Participants who will undergo a standard tru-cut biopsy procedure will need to additionally answer the questionnaire.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Adequacy of tru-cut biopsy in ovarian cancer
- timeFrame
- From the tru-cut biopsy to the histopathological result.
- description
- Evaluation of the adequacy of the procedure in diagnosing ovarian cancer by histopathological and immunohistochemical examination.
Secondary outcomes (1)
- measure
- Accuracy of tru-cut biopsy in ovarian cancer
- timeFrame
- From the tru-cut biopsy to the definitive histopathological examination from the surgery.
- description
- Evaluation of accuracy between tru-cut biopsy and definitive histology in ovarian cancer.
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * suspected advanced ovarian cancer * indication for tru-cut biopsy by multidisciplinary oncoboard Exclusion Criteria: * patient deny to undergo tru-cut biopsy
References
Publications (0)
Data not yet available